NCT00590993CompletedNot Applicable
Magnetic Resonance Imaging and Spectroscopy of the Prostate
Memorial Sloan Kettering Cancer Center1 site in 1 country1,005 target enrollmentStarted: December 2000Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 1,005
- Locations
- 1
- Primary Endpoint
- Determine added value in combining MRSI and MRI in prostate cancer treatment
Study Overview
Brief Summary
Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks at structural and chemical properties of prostates in prostate cancer patients before and after treatment.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •prostate cancer patients willing to undergo a MRI and MRSI exam
Exclusion Criteria
- •patients with prostate cancer and bone or lymph node metastasis
- •patients who can not have an MRI exam
Outcomes
Primary Outcomes
Determine added value in combining MRSI and MRI in prostate cancer treatment
Time Frame: 3 hours
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Active, not recruiting
Not Applicable
Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate CancerLocalized Prostate CancerNCT03814252Turku University Hospital62
Completed
Not Applicable
Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate CancerProstate CancerNCT00310479AHS Cancer Control Alberta16
Unknown
Not Applicable
MRI in Diagnosing Prostate CancerProstate CancerNCT01292291University College London Hospitals714
Completed
Not Applicable
Magnetic Resonance Imaging to Evaluate Prostate CancerProstatic NeoplasmsNCT00182624National Institutes of Health Clinical Center (CC)80
Completed
Not Applicable
MRI/MRSI in Risk Assessment of Prostate Cancer PatientsProstate CancerNCT00582543Memorial Sloan Kettering Cancer Center357